Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease

This study has been completed.
Takeda Pharmaceuticals North America, Inc.
Information provided by (Responsible Party):
Takeda Identifier:
First received: August 25, 2007
Last updated: February 27, 2012
Last verified: February 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2003
  Primary Completion Date: January 2003 (Final data collection date for primary outcome measure)